Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients

American Journal of Transplantation

Volumn 5, Issue 11, 2005, Pages 2710-2718

  Armstrong, Kirsten A ^a   Campbell, Scott B ^a   Hawley, Carmel M ^a   Nicol, David L ^a   Johnson, David W ^a   Isbel, Nicole M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cardiovascular risk; Obesity; Proteinuria; Renal transplantation

Indexed keywords

CREATININE; CYCLOSPORIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TACROLIMUS; TRIACYLGLYCEROL; UREA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GRAFT DYSFUNCTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; KIDNEY TRANSPLANTATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; ALLOTRANSPLANTATION; COMPARATIVE STUDY; MIDDLE AGED; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PREVALENCE; RISK FACTOR; SAMPLE SIZE;

ADULT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY TRANSPLANTATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POSTOPERATIVE COMPLICATIONS; PREVALENCE; PROTEINURIA; RISK FACTORS; SAMPLE SIZE; TRANSPLANTATION, HOMOLOGOUS;

EID: 33644794377     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01073.x     Document Type: Article

References (50)

1. National Institutes of Health. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults-the evidence report. Obes Res 1998 6 ( Suppl 2 51S 209S.
2. Baum CL. Weight gain and cardiovascular risk after organ transplantation. Journal of Parenteral and Enteral Nutrition 2001 25: 114 119.
3. van den Ham EC Kooman JP Christiaans MH Nieman FH van Hooff JP. Weight changes after renal transplantation: a comparison between patients on 5-mg maintenance steroid therapy and those on steroid-free immunosuppressive therapy. Transpl Int 2003 16: 300 306.
4. Meier-Kriesche HU Arndorfer JA Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002 73: 70 74.
5. el Agroudy AE Wafa EW Gheith OE Shehab el-Dein AB Ghoneim MA. Weight gain after renal transplantation is a risk factor for patient and graft outcome. Transplantation 2004 77: 1381 1385.
6. Coates PTH. Obesity is associated with renal allograft failure. Nephrology 2004: 9 ( Suppl 1 A42.
7. Johnson DW Isbel NM Brown AA et al. The effect of obesity on renal transplant outcomes. Transplantation 2002 74: 675 681.
8. Rigatto C. Clinical epidemiology of cardiac disease in renal transplant recipients. Semin Dial 2003 16: 106 110.
9. Halme L Eklund B Salmela K. Obesity and renal transplantation. Transplantation Proceedings 1995 27: 3444 3445.
10. Meier-Kriesche HU Vaghela M Thambuganipalle R Friedman G Jacobs M Kaplan B. The effect of body mass index on long-term renal allograft survival. Transplantation 1999 68: 1294 1297.
11. Pirsch JD Armbrust MJ Knechtle SJ et al. Obesity as a risk factor following renal transplantation. Transplantation 1995 59: 631 633.
12. Alebiosu CO. An update on 'progression promoters' in renal diseases. J Natl Med Assoc 2003 95: 30 42.
13. Iseki K Ikemiya Y Iseki C Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003 63: 1468 1474.
14. Praga M Hernandez E Herrero JC et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 2000 58: 2111 2118.
15. Lietz K Lewandowski Z Lao M Paczek L Gaciong Z. Pretransplant and early posttransplant predictors of chronic allograft nephropathy in cadaveric kidney allograft-a single-center analysis of 1112 cases. Transpl Int 2004 17: 78 88.
16. Levey AS Bosch JP Lewis JB Greene T Rogers N Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 130: 461 470.
17. The National Cholesterol Education Program (NCEP) Expert Panel. Executive Summary of the Third Report of the National Cholesterol Education Programe (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2001. Washington, D.C., US Government Printing Office.
18. Genuth S Alberti KG Bennett P et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003 26: 3160 3167.
19. Friedman AN Miskulin DC Rosenberg IH Levey AS. Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis 2003 41: 480 487.
20. Pfeiffer T Albrecht KH Wagner K Herget S Eigler FW. The effect of obesity on outcome of kidney transplantation. Med Klin (Munich) 1994 89: 635 639.
21. Johnson CP Gallagherlepak S Zhu YR et al. Factors influencing weight-gain after renal-transplantation. Transplantation 1993 56: 822 827.
22. Gill IS Hodge EE Novick AC Steinmuller DR Garred D. Impact of obesity on renal-transplantation. Transplantation Proceedings 1993 25: 1047 1048.
23. Merion RM Twork AM Rosenberg L et al. Obesity and renal-transplantation. Surgery Gynecology & Obstetrics 1991 172: 367 376.
24. Clunk JM Lin CY Curtis JJ. Variables affecting weight gain in renal transplant recipients. American Journal of Kidney Diseases 2001 38: 349 353.
25. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004 89: 2595 2600.
26. Isomaa B Almgren P Tuomi T et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001 24: 683 689.
27. Prabhakaran D Anand SS. The metabolic syndrome: an emerging risk state for cardiovascular disease. Vasc Med 2004 9: 55 68.
28. Aakhus S Dahl K Wideroe TE. Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transplant 1999 14: 648 654.
29. Kasiske BL Vazquez MA Harmon WE et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000 11 ( Suppl 15 S1 86.
30. de Vries AP Bakker SJ van Son WJ et al. Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally. Am J Transplant 2004 4: 1675 1683.
31. Hjelmesaeth J Hartmann A Midtvedt K et al. Metabolic cardiovascular syndrome after renal transplantation. Nephrol Dial Transplant 2001 16: 1047 1052.
32. First MR Neylan JF Rocher LL Tejani A. Hypertension after renal transplantation. J Am Soc Nephrol 1994 4: S30 S36.
33. Kasiske BL Anjum S Shah R et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004 43: 1071 1081.
34. Weir MR. Blood pressure management in the kidney transplant recipient. Adv Chronic Kidney Dis 2004 11: 172 183.
35. Drueke TB Abdulmassih Z Lacour B Bader C Chevalier A Kreis H. Atherosclerosis and lipid disorders after renal transplantation. Kidney Int Suppl 1991 31: S24 S28.
36. Cattran DC Steiner G Wilson DR Fenton SA. Hyperlipidemia after renal transplantation: natural history and pathophysiology. Ann Intern Med 1979 91: 554 559.
37. Vathsala A Weinberg RB Schoenberg L et al. Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients. Transplantation 1989 48: 37 43.
38. Carvalho MF Soares V. Hyperlipidemia as a risk factor of renal allograft function impairment. Clin Transplant 2001 15: 48 52.
39. Cosio FG Pesavento TE Osei K Henry ML Ferguson RM. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001 59: 732 737.
40. Montori VM Basu A Erwin PJ Velosa JA Gabriel SE Kudva YC. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 2002 25: 583 592.
41. Hjelmesaeth J Midtvedt K Jenssen T Hartmann A. Insulin resistance after renal transplantation: impact of immunosuppressive and antihypertensive therapy. Diabetes Care 2001 24: 2121 2126.
42. Reisaeter AV Hartmann A. Risk factors and incidence of posttransplant diabetes mellitus. Transplant Proc 2001 33: 8S 18S.
43. Kasiske BL Snyder JJ Gilbertson D Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003 3: 178 185.
44. Parikh CR Klem P Wong C Yalavarthy R Chan L. Obesity as an independent predictor of posttransplant diabetes mellitus. Transplant Proc 2003 35: 2922 2926.
45. Cosio FG Pesavento TE Kim S Osei K Henry M Ferguson RM. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002 62: 1440 1446.
46. Bear RA Aprile M Sweet J Cole EH. Proteinuria in renal transplant recipients: incidence, cause, prognostic importance. Transplant Proc 1988 20: 1235 1236.
47. Kim HC Park SB Lee SH Park KK Park CH Cho WH. Proteinuria in renal transplant recipients: incidence, cause, and prognostic importance. Transplant Proc 1994 26: 2134 2135.
48. Peddi VR Dean DE Hariharan S Cavallo T Schroeder TJ First MR. Proteinuria following renal transplantation: correlation with histopathology and outcome. Transplant Proc 1997 29: 101 103.
49. Kambham N Markowitz GS Valeri AM Lin J D'agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001 59: 1498 1509.
50. Morales E Valero MA Leon M Hernandez E Praga M. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003 41: 319 327.